Ohio State Navbar


NIH Research Funding

Lauren Bakaletz, PhD 09/30/99-07/31/2020 NIH/NIDCD
Determinants of H.influenzae Virulence in Otitis Media R01DC003915


Derek Houston, PhD 12/1/2015-06/30/2020 NIH/NIDCD  
Infant-directed Speech and Language Development in Infants with Hearing Loss R01DC008581


Pawan Kumar, MS, PhD 07/01/2014-07/31/2017 NIH/NCI
Role of tumor-associated enothelial cells in chaperoning tumor cells R21CA178649


Quintin Pan, PhD 04/08/2015-03/31/2020 NIH/NCI
Cancer Initiating Cells and Treatment Resistance R01CA193590


Qunitin Pan, PhD 05/06/2015-04/30/2020 NIH/NIDCR
Role of P300 in HPV-Positive Head and Neck Cancer R01DE023555


Quintin Pan, PhD 02/01/2016-01/31/2020 NIH/NIGMS
p53/Rb Reactivation Modulators for HPV-positive Head and Neck Cancer R01GM117921


James Rocco, MD, PhD 07/01/2011-04/30/2016 NIDCR/NCI
BCL-2 as a Biomarker for Progrnosis and Therapy of Head and Neck Cancer R01DE022087-01
The major goal of this project is to assess the role of functional Bcl2 status in predicting response to chemo-radiation therapy using the novel technique of BH3 profiling for the first time in oropharyngeal squamous cell carcinoma (OPSCC).


James Rocco, MD, PhD 2013-2016 NIH
Intra-tumor Heterogeneity as a Biomarker of Clinical Outcome in Head and Neck Squamous Cell Carcinoma R01DE022087-03


Gregory Wiet, MD 08/05/11-07/31/16 NIH/NIDCD
Virtual Temporal Bone Surgery: Defining and Translating Standardized Metrics R01DC011321


Kai Zhao, PhD 12/1/2014-11/31/2018 NIH/NIDCD
Objective Evaluation of Conductive Olfactory Losses & Nasal Obstruction Symptoms R01DC013626